Loading
LogicMark, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 12 Nov 2024.
LogicMark, Inc.: what insiders have been doing
LogicMark, Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 18 October 2026, brought 7 filings signed by 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (5,458 companies, median 22 filings), a count of 7 filings is below the norm. Since 2016, the database holds 3 purchases and no sales by insiders of the company.
Insider buying of LogicMark, Inc. has been absent for the past year. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
31
Thresholds
n/a
Buy Volume
€62,387
3 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -88.6%Entry US$480,000.00 · Close at T+365 US$54,937.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.30
Analyst consensus
1 analystsUS$2.25Target US$2.25(+73%)US$2.25
Income statement
RevenueUS$11.4M
Gross profitUS$7.6M67% margin
EBITDA-US$5.8M-51% margin
Net income-US$7.8M-49.6% margin
Valuation
P/Book0.1x
Beta1.46
Balance sheet & cash
Market capUS$1.2M
Total debtUS$48.8k
Free Cash Flow-US$6.5M
Debt / Equity2%
Profitability & ownership
ROE-34.4%
ROA-20.1%
% insiders17.0%
% institutions0.8%
Last declaration on 15 October 2026
Declarations31 total
20,833 shares@ US$1.312.93% mcap73.2% of flowCommon StockSEC:0001213900-26-109829:0
6,300 shares@ US$1.310.89% mcap100.0% of flowCommon StockSEC:0001213900-26-109835:0
20,834 shares@ US$1.312.93% mcap73.2% of flowCommon StockSEC:0001213900-26-109833:0
23,804 shares@ US$1.313.35% mcap75.8% of flowCommon StockSEC:0001213900-26-109832:0
●
Same trade as the filing by Carine Schneider, counted once · View ↗
20,834 shares@ US$1.312.93% mcap55.3% of flowCommon StockSEC:0001213900-26-109830:0
74,965 shares@ US$1.3110.53% mcap90.8% of flowCommon StockSEC:0001213900-26-109828:0
●
Same trade as the filing by John P. Pettitt, counted once · View ↗
20,833 shares@ US$1.312.93% mcap73.2% of flowCommon StockSEC:0001213900-26-109825:0
23,750 shares0Common StockSEC:0001213900-25-106646:0
74,800 shares0Common StockSEC:0001213900-25-106642:0
38,000 shares0Common StockSEC:0001213900-25-001375:0
116,900 shares0Common StockSEC:0001213900-25-001376:0
232,857 shares@ US$0.090637.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-116748:0
Canonical exit: 13 Jan 2025 (T+90)
336,100 shares@ US$0.104762.4% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-109981:0
Canonical exit: 7 Jan 2025 (T+90)
21,486 shares@ US$0.4554100.0% of flowCommon StockSEC:0001213900-24-065868:0
21,486 shares@ US$0.455445.2% of flowCommon StockSEC:0001213900-24-065857:0
21,486 shares@ US$0.4554100.0% of flowCommon StockSEC:0001213900-24-065869:0
21,486 shares@ US$0.4554100.0% of flowCommon StockSEC:0001213900-24-065859:0
21,486 shares@ US$0.4554100.0% of flowCommon StockSEC:0001213900-24-065854:0
21,486 shares@ US$0.4554100.0% of flowCommon StockSEC:0001213900-24-065856:0
46,200 shares0Common StockSEC:0001213900-24-030814:0
62,000 shares0Common StockSEC:0001213900-23-065198:0
20,900 shares0Common StockSEC:0001213900-23-065213:0
10,000 shares@ US$1.14654.8% of flowCommon StockSEC:0001213900-22-034878:0
Canonical exit: 20 Sept 2022 (T+90)
204,145 shares0Common StockSEC:0001213900-22-008497:0
204,145 shares0Common StockSEC:0001213900-22-000546:0
25 of 31 declarations
About LogicMark, Inc.
LogicMark, Inc. is a company specializing in communication technologies for the healthcare sector. It develops security and monitoring solutions for patients and healthcare professionals.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
